Petros Pharmaceuticals In... (PTPI)
NASDAQ: PTPI
· Real-Time Price · USD
0.03
-0.00 (-10.18%)
At close: Jun 09, 2025, 3:15 PM
Petros Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 3.72M | 5.11M | 4.02M | 4.12M | 4.69M | 5.82M | 6.98M | 3.85M | 6.04M | 5.99M | 4.33M | 7.93M | 6.2M | 7.81M | 11.61M | 12.93M | 11.84M |
Cost of Revenue | 880.87K | 1.21M | 1.11M | 1.23M | 1.41M | 1.63M | 2.35M | 2.23M | 2.37M | 2.29M | 1.65M | 1.68M | 1.43M | 1.6M | 3.1M | 3.76M | 3.91M |
Gross Profit | 2.84M | 3.9M | 2.92M | 2.89M | 3.28M | 4.19M | 4.63M | 1.62M | 3.68M | 3.7M | 2.67M | 6.25M | 4.77M | 6.21M | 8.51M | 9.17M | 7.94M |
Operating Income | -7.83M | -10.3M | -13.59M | -16.05M | -16.24M | -13.62M | -12.68M | -21.55M | -20.74M | -19.92M | -23.79M | -13.71M | -16.33M | -18.05M | -14.39M | -13.13M | -13.87M |
Interest Income | 267.74K | 371.77K | 574.62K | 667.28K | 600.81K | 515.31K | 301.92K | 133.44K | 80.51K | 14.19K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -13.36M | -14.32M | -4.73M | -7.06M | -8.94M | -8.16M | -12.71M | -21.98M | -21.25M | -20.04M | -24M | -11.88M | -12.17M | -8.99M | -7.61M | -9.22M | -12.89M |
Net Income | -14.42M | -20.18M | -10.59M | -12.92M | -14.8M | -226.18M | -230.72M | -240M | -239.42M | -16.49M | -20.46M | -8.32M | -8.47M | -8.99M | -6.24M | -7.84M | -11.49M |
Selling & General & Admin | 7.5M | 8.75M | 10.18M | 9.88M | 9.84M | 9.26M | 9.31M | 9.48M | 10.44M | 12.21M | 13.47M | 14.71M | 15.61M | 15.59M | 15.09M | 14.8M | 14.74M |
Research & Development | 1.06M | 2.62M | 3.35M | 3.15M | 3.65M | 2.41M | 1.75M | 2.1M | 1.65M | 1.74M | 2.55M | 2.1M | 2.17M | 1.79M | 951.64K | 707.89K | 339.43K |
Other Expenses | 9.5M | 9.88M | 2.65M | 5.18M | 317.4M | 317.84M | 317.95M | 314.68M | 3.3M | 4.04M | 4.81M | 6.54M | 6.71M | 6.88M | 6.66B | 6.66B | 6.66B |
Operating Expenses | 10.01M | 13.21M | 16.17M | 18.21M | 18.78M | 17.4M | 16.9M | 15.71M | 16.96M | 19.55M | 22.39M | 23.35M | 24.49M | 24.26M | 22.9M | 22.3M | 21.81M |
Interest Expense | 440.7K | 560.91K | 519.27K | 491.89K | 514.18K | 536.14K | 555.26K | 571.59K | 585.16K | 596.02K | 462.86K | 383.12K | 348.27K | 368.66K | 1.17M | 2.08M | 2.72M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -12M | -12M | -12M |
Cost & Expenses | 17.47M | 22.46M | 17.28M | 19.43M | 20.19M | 19.03M | 19.26M | 17.94M | 19.33M | 21.84M | 24.04M | 25.03M | 25.92M | 25.86M | 26M | 26.06M | 25.71M |
Income Tax Expense | 12.47B | 12.48B | 5.99M | 6.86M | -76.88M | 135.27M | 135.13M | 134.28M | 218.17M | -3.55M | -3.55M | -3.55M | -3.7M | 173.41K | -1.19M | -1.2M | -1.22M |
Shares Outstanding (Basic) | 1.16M | 80.26M | 4.16M | 1.79M | 1.28M | 151.49K | 1.6M | 2.12M | 2.09M | 2.08M | 2.07M | 2.07M | 2.07M | 1.42M | 982.66K | 960.42K | 975.31K |
Shares Outstanding (Diluted) | 1.16M | 80.26M | 9.83M | 7.39M | 4.76M | 2.38M | 2.12M | 2.12M | 2.09M | 2.08M | 2.07M | 2.07M | 2.07M | 1.42M | 982.66K | 980.23K | 975.47K |
EPS (Basic) | -2.98 | -2.72 | -4.69 | -7.01 | -7.84 | -6.81 | -6.74 | -10.58 | -10.26 | -9.68 | -13.42 | -8.46 | -9.74 | -6.57 | -5.72 | -13.6 | -28.22 |
EPS (Diluted) | -2.98 | -2.72 | -4.69 | -7.01 | -7.84 | -6.81 | -6.74 | -10.58 | -10.26 | -9.68 | -13.43 | -8.47 | -9.79 | -6.62 | -5.76 | -13.64 | -28.24 |
EBITDA | -10.98M | -10.81M | -996.68K | -3.29M | -5.05M | -4.15M | -8.7M | -17.19M | -15.74M | -13.81M | -16.92M | -6.71M | -6.85M | -3.45M | 190.52K | 1.38M | -1.74M |
EBIT | -11.72M | -13.76M | -9.69M | -12.05M | -13.91M | -13.11M | -12.16M | -21.41M | -20.66M | -19.44M | -23.54M | -11.49M | -11.82M | -8.62M | -6.43M | -7.14M | -10.17M |
Depreciation & Amortization | 2.19M | 2.94M | 3.21M | 3.27M | 3.37M | 3.48M | 3.46M | 4.19M | 4.93M | 5.66M | 6.43M | 6.63M | 6.79M | 6.95M | 6.94M | 6.87M | 6.78M |